Fresenius a “Top Performer” in its Sector
Fresenius Medical Care is a leader in the MedTech sector, with a “Buy” rating from Zacks. An international company with a diversified product range, both revenue and net income to shareholders is expected to rise.
Read the full article » | Posted 04-12-2018
Related Articles
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026
- Somatus to Open Maryland Home Dialysis Training Center Posted 09-18-2026
- DaVita and Humana Partner to Care for 10,000 Medicare Advantage Members with CKD Posted 09-18-2026

